STAAR Surgical Co OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment and Tax
STAAR Surgical Co (STAA) reported OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment and Tax of -$11.00 thousand for the 3-month period ending 2026-07-03, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax · last filed 2026-08-12
- STAAR Surgical Co oci, debt securities, available-for-sale, gain (loss), before adjustment and tax for the quarter ending 2026-07-03 was -$11.00K, a 222.22% decline year-over-year.
- STAAR Surgical Co oci, debt securities, available-for-sale, gain (loss), before adjustment and tax for the quarter ending 2026-04-03 was -$5.00K.
- STAAR Surgical Co oci, debt securities, available-for-sale, gain (loss), before adjustment and tax for the quarter ending 2026-01-02 was $0.00.
- STAAR Surgical Co oci, debt securities, available-for-sale, gain (loss), before adjustment and tax for the quarter ending 2025-09-26 was $3.00K, a 97.76% decline year-over-year.
- STAAR Surgical Co oci, debt securities, available-for-sale, gain (loss), before adjustment and tax for fiscal 2026 was $11.00K, a 60.71% decline from fiscal 2024.
- STAAR Surgical Co oci, debt securities, available-for-sale, gain (loss), before adjustment and tax for fiscal 2024 was $28.00K, a 92.29% decline from fiscal 2023.
- STAAR Surgical Co oci, debt securities, available-for-sale, gain (loss), before adjustment and tax for fiscal 2023 was $363.00K.
- STAAR Surgical Co oci, debt securities, available-for-sale, gain (loss), before adjustment and tax for fiscal 2022 was -$406.00K.
| Period end | OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment and Tax 3 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment and Tax 6 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment and Tax 9 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment and Tax 12 month |
|---|---|---|---|---|
| 2026-07-03 | -$11.00K 10-Q · filed 2026-08-12 | -$16.00K 10-Q · filed 2026-08-12 | -$16.00K derived: sum of 3 quarters · filed 2026-08-12 | -$13.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-04-03 | -$5.00K 10-Q · filed 2026-05-13 | -$5.00K derived: sum of 2 quarters · filed 2026-05-13 | -$2.00K derived: sum of 3 quarters · filed 2026-05-13 | $7.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-01-02 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $3.00K derived: sum of 2 quarters · filed 2026-03-03 | $12.00K derived: sum of 3 quarters · filed 2026-08-12 | $11.00K 10-K · filed 2026-03-03 |
| 2025-09-26 | $3.00K 10-Q · filed 2025-11-05 | $12.00K derived: sum of 2 quarters · filed 2026-08-12 | $11.00K 10-Q · filed 2025-11-05 | -$62.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-27 | $9.00K 10-Q · filed 2026-08-12 | $8.00K 10-Q · filed 2026-08-12 | -$65.00K derived: sum of 3 quarters · filed 2026-08-12 | $69.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-28 | -$1.00K 10-Q · filed 2026-05-13 | -$74.00K derived: sum of 2 quarters · filed 2026-05-13 | $60.00K derived: sum of 3 quarters · filed 2026-05-13 | $63.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-27 | -$73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $61.00K derived: sum of 2 quarters · filed 2026-03-03 | $64.00K derived: sum of 3 quarters · filed 2026-03-03 | $28.00K 10-K · filed 2026-03-03 |
| 2024-09-27 | $134.00K 10-Q · filed 2025-11-05 | $137.00K derived: sum of 2 quarters · filed 2025-11-05 | $101.00K 10-Q · filed 2025-11-05 | $341.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-06-28 | $3.00K 10-Q · filed 2025-08-06 | -$33.00K 10-Q · filed 2025-08-06 | $207.00K derived: sum of 3 quarters · filed 2026-03-03 | $356.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-03-29 | -$36.00K 10-Q · filed 2025-05-07 | $204.00K derived: sum of 2 quarters · filed 2026-03-03 | $353.00K derived: sum of 3 quarters · filed 2026-03-03 | $211.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2023-12-29 | $240.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $389.00K derived: sum of 2 quarters · filed 2026-03-03 | $247.00K derived: sum of 3 quarters · filed 2026-03-03 | $363.00K 10-K · filed 2026-03-03 |
| 2023-09-29 | $149.00K 10-Q · filed 2024-10-30 | $7.00K derived: sum of 2 quarters · filed 2024-10-30 | $123.00K 10-Q · filed 2024-10-30 | $149.00K derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-06-30 | -$142.00K 10-Q · filed 2024-08-07 | -$26.00K 10-Q · filed 2024-08-07 | $0.00 derived: sum of 3 quarters · filed 2025-02-21 | -$432.00K derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-03-31 | $116.00K 10-Q · filed 2024-05-07 | $142.00K derived: sum of 2 quarters · filed 2025-02-21 | -$290.00K derived: sum of 3 quarters · filed 2025-02-21 | |
| 2022-12-30 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | -$406.00K derived: sum of 2 quarters · filed 2025-02-21 | -$406.00K 10-K · filed 2025-02-21 | |
| 2022-09-30 | -$432.00K 10-Q · filed 2023-11-06 | -$432.00K 10-Q · filed 2023-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |